342 related articles for article (PubMed ID: 28485183)
1. Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?
Melero Cortés LM; Martínez Maestre MÁ; Vieites Pérez-Quintela MB; Gambadauro P
J Obstet Gynaecol; 2017 Jul; 37(5):655-659. PubMed ID: 28485183
[TBL] [Abstract][Full Text] [Related]
2. Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature.
Durmuş Y; Kılıç Ç; Çakır C; Yüksel D; Boran N; Karalök A; Boyraz G; Turan AT
J Obstet Gynaecol Res; 2019 Jul; 45(7):1311-1318. PubMed ID: 31106943
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors.
Zhang HY; Zhu JE; Huang W; Zhu J
Int J Clin Exp Pathol; 2014; 7(10):6956-64. PubMed ID: 25400781
[TBL] [Abstract][Full Text] [Related]
4. Outcomes among patients with sex cord stromal tumour of ovary: experience from Pakistan.
Sarwar S; Siddiqui N; Ather S; Hannan A; Ali Syed A; Zafar W
J Ayub Med Coll Abbottabad; 2014; 26(3):389-92. PubMed ID: 25671955
[TBL] [Abstract][Full Text] [Related]
5. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.
Sigismondi C; Gadducci A; Lorusso D; Candiani M; Breda E; Raspagliesi F; Cormio G; Marinaccio M; Mangili G
Gynecol Oncol; 2012 Jun; 125(3):673-6. PubMed ID: 22446621
[TBL] [Abstract][Full Text] [Related]
7. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature.
Gressel GM; Buza N; Pal L
Eur J Gynaecol Oncol; 2017; 38(2):214-220. PubMed ID: 29953783
[TBL] [Abstract][Full Text] [Related]
9. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
10. Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT).
Schneider DT; Orbach D; Cecchetto G; Stachowicz-Stencel T; Brummel B; Brecht IB; Bisogno G; Ferrari A; Reguerre Y; Godzinski J; Bien E; Calaminus G; Göbel U; Patte C
Eur J Cancer; 2015 Mar; 51(4):543-550. PubMed ID: 25514863
[TBL] [Abstract][Full Text] [Related]
11. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review.
Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Sertoli-Leydig cell tumor of ovary in 8-year-old girl.
Turkyilmaz Z; Karabulut R; Ozbakir F; Pinarli G; Arda Inan M; Oguz A; Sonmez K
Scott Med J; 2016 Feb; 61(1):56-9. PubMed ID: 27334531
[TBL] [Abstract][Full Text] [Related]
13. Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients.
Akman L; Ertas IE; Gokcu M; Terek MC; Sanci M; Sanli UA; Zekioglu O; Ozsaran AA
J Cancer Res Ther; 2016; 12(1):290-4. PubMed ID: 27072253
[TBL] [Abstract][Full Text] [Related]
14. [Sertoli-Leydig cell tumor of the ovary: case study of a 22-year old woman].
Moussa D; Aziz DA; Niassy DA; Espérence KC; Youssou N; Charles MJ; Alassane D
Pan Afr Med J; 2016; 25():36. PubMed ID: 28154727
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.
Fanta M; Fischerová D; Indrielle-Kelly T; Koliba P; Zdeňková A; Burgetová A; Vrbíková J
J Obstet Gynaecol; 2019 Apr; 39(3):359-364. PubMed ID: 30428740
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Sertoli-Leydig cell tumour with α-fetoprotein-producing intestinal glandular cells. Clinical case and short review of basic literature.
Strus M; Rajtar-Ciosek A; Jach R; Hankus J; Szczepański W
Pol J Pathol; 2019; 70(3):226-231. PubMed ID: 31820869
[TBL] [Abstract][Full Text] [Related]
17. Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
[TBL] [Abstract][Full Text] [Related]
18. Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings.
Mooney EE; Nogales FF; Bergeron C; Tavassoli FA
Histopathology; 2002 Aug; 41(2):110-7. PubMed ID: 12147087
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors.
Gui T; Cao D; Shen K; Yang J; Zhang Y; Yu Q; Wan X; Xiang Y; Xiao Y; Guo L
Gynecol Oncol; 2012 Nov; 127(2):384-9. PubMed ID: 22850410
[TBL] [Abstract][Full Text] [Related]
20. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
